Elanco Animal Health (ELAN) Gross Profit (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Gross Profit data on file, last reported at $785.0 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 14.77% year-over-year to $785.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 billion (up 10.86% YoY), and the FY2025 full-year result was $2.6 billion, up 6.44% from the prior year.
• Gross Profit grew to $785.0 million in Q1 2026, from $589.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $785.0 million in Q1 2026 to a low of $519.0 million in Q4 2023.
• A 5-year average of $635.2 million and a median of $623.0 million in 2023 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit fell 11.92% in 2022 and advanced 14.77% in 2026, its largest moves.
• Tracing ELAN's Gross Profit over 5 years: stood at $537.0 million in 2022, then slipped by 3.35% to $519.0 million in 2023, then changed by 0.0% to $519.0 million in 2024, then gained by 13.49% to $589.0 million in 2025, then soared by 33.28% to $785.0 million in 2026.
• Business Quant data shows ELAN's Gross Profit at $785.0 million in Q1 2026, $589.0 million in Q4 2025, and $607.0 million in Q3 2025.